Patents Assigned to University of Santiago de Compostela
  • Agent for capturing tumor cells and methods of use thereof
    Patent number: 10111935
    Abstract: The present invention relates to a composition for modulating tumor cell dissemination, in particular metastatic cancer cells. In particular, the invention relates to an agent for modulating metastatic tumor cell dissemination for use in the treatment and/or prevention of a metastatic cancer wherein the agent comprises an extracellular matrix (ECM) protein carried on a polycarbonate polyurethane matrix, and wherein the agent binds to tumor cells when implanted in a body. The invention also relates to a product, comprising an agent for modulating metastatic tumor cell dissemination, and to a method of treatment or prevention of cancer.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: October 30, 2018
    Assignees: FUNDACIÖN PEDRO BARRIÉ DE LA MAZA, CONDO DE FENOSA, SERGAS, UNIVERSITY OF SANTIAGO DE COMPOSTELA, FUNDACION RAMÓN DOMINGUEZ, BIOMERIX CORPORATION
    Inventors: Alexandre De La Fuente Gonzalez, Rafael Lopez, Miguel Abal Posada, Lawrence Patrick Lavelle, Jr.
  • AGENT, PRODUCT AND USE
    Publication number: 20170246258
    Abstract: The present invention relates to a composition for modulating tumor cell dissemination, in particular metastatic cancer cells. In particular, the invention relates to an agent for modulating metastatic tumor cell dissemination for use in the treatment and/or prevention of a metastatic cancer wherein the agent an extracellular matrix (ECM) protein carried on a polycarbonate polyurethane matrix. The invention also relates to a product, comprising an agent for modulating metastatic tumor cell dissemination, and to a method of treatment or prevention of cancer.
    Type: Application
    Filed: April 30, 2015
    Publication date: August 31, 2017
    Applicants: FUNDACIÓN PEDRO BARRIÉ DE LA MAZA, CONDE DE FENOSA, SERGAS, UNIVERSITY OF SANTIAGO DE COMPOSTELA, FUNDACION RAMÓN DOMINGUEZ, BIOMERIX CORPORATION
    Inventors: Alexandre DE LA FUENTE GONZALEZ, Rafael LOPEZ, Miguel Abal POSADA, Lawrence Patrick LAVELLE, Jr.
  • AGENT, PRODUCT AND USE
    Publication number: 20170049860
    Abstract: The present invention relates to a composition for modulating tumor cell dissemination, in particular metastatic cancer cells. In particular, the invention relates to an agent for modulating metastatic tumor cell dissemination for use in the treatment and/or prevention of a metastatic cancer wherein the agent an extracellular matrix (ECM) protein carried on a polycarbonate polyurethane matrix. The invention also relates to a product, comprising an agent for modulating metastatic tumor cell dissemination, and to a method of treatment or prevention of cancer.
    Type: Application
    Filed: April 30, 2015
    Publication date: February 23, 2017
    Applicants: Fundacion Pedro Barrie De La Maza,Conde De Fenosa, Sergas, University of Santiago De Compostela, Fundacion Ramon Dominguez, Biomerix Corporation
    Inventors: Alexandre DE LA FUENTE GONZALEZ, Rafael LOPEZ, Miguel Abal POSADA, Lawrence Patrick LAVELLE, JR.
  • Neutron dosimetry for radiotherapy
    Patent number: 8188440
    Abstract: A system includes emission of a first treatment beam associated with a first energy toward a neutron dose detector, determination of a first number of soft errors experienced by a semiconductor-based device exposed to neutrons generated by the first treatment beam, determination of a first neutron dose based on the first treatment beam using the neutron dose detector, and association of the first energy of the first treatment beam with the first number of soft errors and the first neutron dose. Some aspects include emission of a second treatment beam associated with the first energy toward a target, determination of a second number of soft errors experienced by the semiconductor-based device exposed to neutrons generated by the second treatment beam, and determination of a second neutron dose at the target based on the association between the first energy, the first number of soft errors and the first neutron dose.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: May 29, 2012
    Assignees: Siemens Medical Solutions USA, Inc., University of Santiago de Compostela
    Inventors: Faustino Gómez Rodríguez, Francisco Miguel Hernandez-Guerra, Alfredo Iglesias Lago
  • Process to obtain ultra fine magnetic Nd-Fe-B particles of various sizes
    Patent number: 4983217
    Abstract: Process to obtain ultra fine magnetic Nd-Fe-B particles of various sizes, which can cause a reaction in different kinetic conditions, between compounds of Nd, Fe and B in the sine of micro-emulsions formed by water, oil and a surface-active agent, in different thermodynamic conditions.
    Type: Grant
    Filed: November 22, 1989
    Date of Patent: January 8, 1991
    Assignee: University of Santiago de Compostela
    Inventors: Manuel A. Lopez Quintela, Jose Rivas Rey, Jose Quiben Solla